2019
DOI: 10.11648/j.avs.20190705.11
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Type and Dose of Recombinant Human Follicle Stimulating Hormone on Embryos Production in Dairy Cows and Their Relationship with AMH Concentration

Abstract: The study was investigated to compare the effectiveness of Folltropin and two products (Fostimon and Menogon) of a recombinant human follicle stimulating hormone (rhFSH) on ovarian super-stimulation and embryo production in dairy Holstein cows. Two different doses for each super-ovulatory product were investigated. The relationship between the levels of Anti-Mullerian Hormone (AMH) in the blood serum before super-stimulation initiation and ovarian response and embryos production were also evaluated. At random … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…(2006) [4] did not record any significant difference in the superovulatory response between groups. These variations between two doses might be due to individual differences in the follicle population in the ovary (Mohammed et al 2019) [17] and dose of Folltropin ® V stimulation on antral follicles of Group II donor cows. Further, ovarian response is related with differences in treatments such as total dose, duration and timing of treatment and the use of additional hormones in the treatment protocol (Son et al 2007) [26] .…”
Section: Resultsmentioning
confidence: 99%
“…(2006) [4] did not record any significant difference in the superovulatory response between groups. These variations between two doses might be due to individual differences in the follicle population in the ovary (Mohammed et al 2019) [17] and dose of Folltropin ® V stimulation on antral follicles of Group II donor cows. Further, ovarian response is related with differences in treatments such as total dose, duration and timing of treatment and the use of additional hormones in the treatment protocol (Son et al 2007) [26] .…”
Section: Resultsmentioning
confidence: 99%